Podcasts about bioengineering

In this episode of Let's Combinate, host Subhi Saadeh is joined by Kirk Petyo, Managing Partner at Talent Factory Medical and founder of Talent Factory Recruiting. If you're a bioengineering student, recent grad, or early-career professional trying to break into medical devices, biotech, or pharma—this one's for you.With extensive experience recruiting for regulated industries like aerospace, medical devices, and pharmaceuticals, Kirk offers grounded, actionable insights for early-career professionals and hiring managers alike.This episode covers how to craft a strong resume, the importance of knowing your career “why,” how to stand out to recruiters, and why onshoring and shifting regulatory trends matter for the next generation of talent in life sciences.Timestamps00:00 – Welcome and Guest Introduction 00:35 – Kirk's Career Journey and Advice 02:18 – Navigating Early Career Challenges 03:12 – Building a Strong Resume and Networking 04:38 – The Importance of Specificity in Job Applications 08:56 – Recruitment Insights and Industry Trends 12:05 – Personal Experiences and Lessons Learned 18:49 – Advice for Upcoming Graduates 23:18 – The Importance of Passion in Job Interviews 24:00 – Evaluating Candidates Beyond Experience 24:58 – Personal Stories and Career Choices 30:55 – Bioengineering vs. Mechanical Engineering 41:34 – Industry Trends and Onshoring 44:18 – Entry-Level Opportunities and Recruitment About Kirk PetyoKirk Petyo is the Managing Partner at Talent Factory Medical and founder of Talent Factory Recruiting. He has spent his career recruiting top talent in highly regulated industries like aerospace, medical devices, biotech, and pharma. Known for his ability to bridge business needs with real human connections, Kirk helps companies grow stronger teams—and helps candidates navigate complex career decisions with clarity and purpose.About the Host Subhi Saadeh is a Quality Professional and host of Let's ComBinate. With a background in Quality, Manufacturing Operations, and R&D, he has worked in large Medical Device and Pharma organizations to support the development and launch of hardware devices, disposable devices, and combination products for vaccines, generics, and biologics.Subhi currently serves as the International Committee Chair for the Combination Products Coalition (CPC), is a member of ASTM Committee E55, and has served on AAMI's Combination Products Committee.

Bioengineering is a complex field. In some industries it's well established, in others still nascent. But one thing is true regardless of where it's applied – it poses interesting problems. Dr Hamid Noori is one scientist motivated by solving these kinds of big, difficult and (he would say) fun problems. As CEO of bioengineering company, The Cultivated B, his work takes cellular technologies from the lab to the market. On this episode, filmed live at the Rulebreaker Future Congress in Germany, he shares how a grand purpose in life is not necessary if you have audacious problems that you are focused on solving and an openness to solving them in new ways.----------More:Looking Outside podcast www.looking-outside.comConnect with host, Jo Lepore on LinkedIn & X & jolepore.comLearn more about Hamid Noori & Cultivated BFollow Hamid on LinkedIn & his writing on Forbes Technology CouncilFollow Cultivated B on LinkedInCheck out Hamid's other ventures n!Biomachines & PreFerIndustries Learn more on the Rulebreaker Future Congress & the Rulebreaker Society----------⭐ Follow & rate the show - it makes a difference!----------Looking Outside is a podcast exploring fresh perspectives of familiar topics. Hosted by its creator, futurist and strategist, Jo Lepore. New episodes every 2 weeks. Never the same topic.All views are that of the host and guests and don't necessarily reflect those of their employers. Copyright 2025. Theme songs by Azteca X.

Christopher R. Daubert, Ph.D., serves as the President of the Institute of Food Technologists (IFT) and as the Vice Chancellor and Dean of the College of Agriculture, Food, and Natural Resources at the University of Missouri (Mizzou), as well as a Professor in the Division of Food Systems and Bioengineering. He joined Mizzou from North Carolina State University, where he served as a Professor and Head of the Department of Food, Bioprocessing, and Nutrition Services; Director of the Food Rheology Laboratory; and system Co-Chair of Food, Biochemical, and Engineered Systems. His research explained the physical chemistry, molecular-level interactions, and functionality of food systems through an understanding of rheological behavior, while solving problems facing the food and pharmaceutical industries.  Dr. Daubert has received distinguished alumnus awards from Pennsylvania State University and Michigan State University. He is also a Fellow of IFT and previously served IFT as chair of the Food Engineering Division and a member-at-large of the Dogwood section. He holds a B.S. degree in Agricultural Engineering from Penn State University, a Ph.D. in Agricultural Engineering and Food Science from Michigan State University, and a Post-Doctorate in Food Science from North Carolina State University.   In this episode of Food Safety Matters, we speak with Dr. Daubert [23:34] about: The challenges and opportunities for attracting students to food science and other food-related academic programs The value of an education in food science The role the food industry plays in food science education The complex food system challenges that today's students—tomorrow's workforce—can help address Dr. Daubert's work at Mizzou in promoting food science education How IFT helps prepare students to contribute to the global food community upon graduation. News USDA Secretary Rollins Increases Funding to Reimburse States for Food Safety Inspections [3:34]Senator Cotton Introduces Bill to Consolidate Federal Food Safety Agencies [6:38]MAHA Report Sets Stage for Overhaul of Food Chemicals, Environmental Contaminants, and Childhood Nutrition [10:18]Mars Removes Titanium Dioxide from Skittles in the United States [21:41] Sponsored by: CINTAS   We Want to Hear from You! Please send us your questions and suggestions to podcast@food-safety.com

Manu Prakash is many things—biologist, engineer, inventor, philosopher—but what he isn't is conventional. Following his instincts has led Manu to his most ambitious project yet: mapping the whole tree of life, with the help of everyone on this planet. Step one: make a cheap microscope anyone can use. Foldscope co-inventor Jim Cybulski describes their invention, and their dream to supply millions of microscopes to the masses. Manu has been recognized by the Hypothesis Fund as a Scout for his bold science and enabling others to pursue their big ideas. “The Leap” is a 10-episode audio series that profiles scientists willing to take big risks to push the boundaries of discovery. It premieres on Science Friday's podcast feed every Monday until July 21. “The Leap” is a production of the Hypothesis Fund, brought to you in partnership with Science Friday.Transcript is available on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

This week on H-Span, we are joined by Dr. Irina and Michael Conboy of the Department of Bioengineering at the University of California BerkeleyIn this episode, we discuss their breakthrough work with therapeutic plasma exchange, the recent A4LI D.C. Summit, and how young scientists can get involved in the longevity space.

Dr. Jin Hyung Lee is an electrical engineer focused on understanding the circuits of the human brain and how they relate to brain disorders. She is an associate professor of Neurology, Neurosurgery, Bioengineering, and Electrical Engineering at Stanford University. Her work with LVIS has led to the creation of NeuroMatch which focuses on mapping the brain to help with diagnosing brain disorders and creating new treatments for brain issues.    You can following the work of LVIS at: https://lviscorp.com/en/ Follow on YoutTube at: www.youtube.com/@LVISNeuroMatch Follow Dr. Jin on X @ljinhy   Mental Maps is brought to up by Arukah Well. Learn more at www.arukahwell.co    

Die Themen in den Wissensnachrichten: +++ Europa muss sich auf mehr extreme Waldbrände einstellen +++ Laufschuh-Dämpfung ist oft schlecht +++ Bestimmte Kohlenhydrate können länger gesundhalten +++**********Weiterführende Quellen zu dieser Folge:Changing Wildfires - Policy Options for a Fire-literate and Fire-adapted Europe, EASAC, 19.05.2025A New Method and Set of Parameters for Evaluating the Cushioning Effect of Shoe Heels, Revealing the Inadvertent Design of Running Shoes, Bioengineering, 28.04.2025Dietary Carbohydrate Intake, Carbohydrate Quality, and Healthy Aging in Women, JAMA Network Open, 16.05.2025Die Geschichte der Kinderkuren und Kindererholungsmaßnahmen in der Bundesrepublik Deutschland zwischen 1945 und 1989, Humboldt-Universität zu Berlin, 15.05.2025Emergent social conventions and collective bias in LLM populations, Science Advances, 14.05.2025Alle Quellen findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok und Instagram .

Research in the past has indicated that neurological disorders such as Alzheimer's disease are non-infectious. But what if it was possible to catch a brain infection? Joining us to discuss this fascinating topic is Dr. Or Shemesh, an expert working to build and utilize new technologies to study and reverse brain disease… Dr. Shemesh is an Assistant Professor at the University of Pittsburgh School of Medicine, Departments of Neurobiology and Bioengineering. Here, he works in a cutting-edge field called “Counter Disease Engineering” – otherwise known as a technological approach to understanding diseases of the nervous system.  In this conversation, we cover: The major causes of inflammation. The unique connection between nervous system diseases and infectious agents.  How microbes impact our overall health.  How brain pathogens are potentially connected to Alzheimer's.  You can learn more about Dr. Shemesh and his work here! Episode also available on Apple Podcasts: http://apple.co/30PvU9C

In this episode, we discuss the anti-aging effects of therapeutic plasma exchange (TPE) with Dr. Irina Conboy, a professor in the Department of Bioengineering at UC Berkeley. Her current research focuses on unraveling the key signal transduction pathways that regulate adult stem cell behavior – and understanding how these pathways change with age… From synthetic biology to CRISPR technologies, Dr. Conboy has been working in the fields of aging and genetic diseases for decades. Is aging a disease that can be solved? If so, what role does TPE play in it? If you're interested in the mysterious topic of human aging, this podcast is undoubtedly for you! Jump in to find out: What TPE is, and what it's used for.  The benefits of “rebooting” blood signal proteins. What blood plasma is, and how it is produced in the human body. How TPE is linked to anti-aging.   You can follow along with Dr. Conboy and her lab's work here. Episode also available on Apple Podcasts: http://apple.co/30PvU9C

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

Andy Constan stops by to discuss today's US macro backdrop. Importantly, this discuss was recorded on 4/24. Since then the narrative around the tax bill has gotten incrementally more stimulative. Do what you will with that information.Bill reached out to Andy after following him for a while on Twitter. Andy appears to use Twitter to educate, inform, and journal thoughts. Hence why he was invited to the show.As for Andy's formal background, his bio reads as follows:Andy Constan graduated with a degree in Bioengineering from the University of Pennsylvania in 1986.Following he spent 35 years investing and trading global equities, spending 17 years at Salomon Brothers.Following he started honing his Macroeconomic Knowledge in 2010 working at Bridgewater Associates and Brevan Howard.Since then he has worked on growing Damped Spring Advisors.We hope you enjoy the conversation.

Join T, Father Fortenberry, Gary and Marty Mar the Bourbon Nerd as they discuss headlines of the day. Momfluencers gone wild - what will they not do for $$$Bioengineering - What is a Wolly Mouse and why should be care?The empire strikes back - and we are not talking about the Trade war, or are we? All that and much more on today on the Patio!Buy some Merch:https://lifefromthepatio.com/merchfollow us on TikTok:https://tiktok.com/@lifefromthepatio2 #bourbon #whiskey #fye #KnobCreek#Jack Daniels#comedy #podcast#funnyvideo #buffalotrace #distillery#buffalo #LFTP#oldforester #jimbeam #heavenhill#Bluenote#Shortbarrel#rye #ark #arknights#arkansas #nba #nfl #razorbacks #newyears #resolutions#LFTP Fred Minnick

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Philip Lee, CEO at GeneFab. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Philip, covering: The role of luck in the development of his entrepreneurial journey of multiple biopharma start-ups Bootstrapping a biological tech company and then selling to Millipore, along with lessons learnt from a more prominent global organization Building a new company from the back of a napkin to an IPO on the NASDAQ Creating a technology platform and operational capability with real therapeutic application that led to the spin-out of Genefab Bridging the gap for early-stage cell therapy companies with aligned incentives and a non-transactional model Philip Lee is a bioengineer, biotechnology entrepreneur, and executive who has spent the last 20 years building companies and commercializing products, including cell and gene therapies, synthetic biology platforms, scientific instrumentation, cell culture systems, and advanced manufacturing services. He has been the “first employee” at multiple ventures with leadership experience across diverse growth trajectories, including bootstrapping, VC and PE funding rounds, IPO, acquisition, and internal innovation within a large enterprise. Philip holds degrees from the Massachusetts Institute of Technology and the UC Berkeley/UCSF Joint Graduate Program in Bioengineering. Philip is currently the founding CEO of GeneFab, a contract research, development, and manufacturing organization focused on supporting its clients in bringing innovative genetic medicines to needy patients.  Before GeneFab, Philip was the Co-Founder and CTO of Senti Biosciences, a cell and gene therapy company applying gene circuit technology to improve the efficacy and safety of cancer cell therapies. Philip was also the co-founder and CEO of Cellasic Corp, a microfluidics instrumentation company that MilliporeSigma had acquired. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

Listen to this episode if you: are an early career engineer, are contemplating a career change, or just like engineering career stories.This Week in LinkedIn Lunatics:⁠⁠1. Still in college but ready to strangle my friend who said this yesterday

Cara Bognar is the Founder of Top Tier Lessons, a sports technology platform that connects collegiate student athletes with parents looking for sports lessons for their children.  She's an athlete herself, as a former team captain for Illini Swimming & Diving, and graduated from UIUC with dual degrees in Bioengineering and Innovation Leadership and Engineering Entrepreneurship (ILEE).Cara's LinkedIn- https://www.linkedin.com/in/carabognar/Top Tier Lessons- https://www.toptierlessons.com/VISIT http://researchpark.illinois.edu/podcast/ for our entire catalog of episodes.

In this episode, I talked to Dr. Karolina Valente, CEO of Voxcell BioInnovation. Dr. Valente talks about how her company, Voxcell, is trying to revolutionize the drug development process by developing customizable 3D tissue models to test different therapeutics and drugs. We also talked about how AI will affect future drug trials, Vancouver's potential as a biotech hub, improvements needed to strengthen Canada's biotech industry, Voxcell's new and old products, and the difficulty of raising money to go to different rounds. ---------------------------------------------------------------Thanks to the sponsors:Audible: Use my link for a 30-day free trial: http://audibletrial.com/diamondgoatNewsly: https://newsly.mepromo code to receive a 1-month free premium subscription: EARLYMORNING Libysn: https://libsyn.compromo code: DG Dubby Energy: https://www.dubby.ggpromo code for 10% off: DIAMONDGOATOpus Clips:  https://www.opus.pro/?via=diamondgoat----------------------------------------------------------------------------------Listen on:Podcast website: https://www.spreaker.com/podcast/dg-early-morning-show--5943922Spotify: https://open.spotify.com/show/0EuhA6WyuerHtVAqcFrFeOPodcast YT channel clips: https://www.youtube.com/@dgearlymorningshowTiktok: @dgearlymorningshowApple Podcast: https://podcasts.apple.com/us/podcast/dg-early-morning-show/id1575451533Amazon Music: https://music.amazon.com/podcasts/f050b86c-1dad-4bc3-b12f-6aa5fa62438c  Goodpods: https://goodpods.com/podcasts/dg-early-morning-show-211830RadioPublic: https://radiopublic.com/dg-earlymorning-show-WoML4rBreaker: https://www.breaker.audio/dg-early-morning-showReason: https://reason.fm/podcast/dg-earlymorning-show--------------------------------------Check out my other stuff:Instagram: @itzdiamondgoatTwitter: @lildiamondgoatMain YT channel: youtube.com/diamondgoatTiktok: @lildiamondgoatSoundcloud: @Lil DiamondgoatSpotify: @Lil DiamondgoatMerch store: https://diamondgoat.creator-spring.com

London scientists have developed a new material called Roliner which allows amputees to adjust the fit of prosthetic limbs.Our bodies change shape during the day which can be uncomfortable for amputees if their prosthetics don't fit properly.To find out more, we're joined by Professor Firat Guder from Imperial's Department of Bioengineering, one of the researchers behind Roliner. Also in this episode:Spring Statement: Rachel Reeves says £400m will be allocated to 'bring innovative technology to the front line'Could Trump cut tariffs on China to complete a TikTok deal?Why social media has been flooded with Ghibli-style AI-generated imagesAbba ‘adding a little something' to their avatar arena showsLucky! Two medieval rings found by metal detectorists sell at auction for… Hosted on Acast. See acast.com/privacy for more information.

The Soil Matters with Dr. Gerald PollackSeason 3, Episode 07 Today's Guest: Dr. Gerald PollackGerald Pollack received his PhD in biomedical engineering from the University of Pennsylvania in 1968. He then joined the University of Washington faculty and is now professor of Bioengineering. He is also Founding Editor-in-Chief of the journal, WATER, convener of the Annual Conference on the Physics, Chemistry and Biology of Water, and Executive Director of the Institute for Venture Science. His interests have ranged broadly, from biological motion and cell biology to the interaction of biological surfaces with aqueous solutions. His 1990 book, Muscles and Molecules: Uncovering the Principles of Biological Motion, won an “Excellence Award”from the Society for Technical Communication. His 2001 book, Cells, Gels and the Engines of Life, and his newest book, The Fourth Phase of Water: Beyond Solid, Liquid,and Vapor won that Society's “Distinguished Award,”their highest distinction. The latter book went on to receive the World Summit Excellence Award. Pollack received an honorary doctorate in 2002 fromUral State University in Ekaterinburg, Russia, and was more recently named an Honorary Professor of the Russian Academy of Sciences, and foreign member and Academician of the Srpska Academy. He received the Biomedical Engineering Society's Distinguished Lecturer Award in 2002. In 2008, his colleagues chose him as the recipient of his university's highest annual distinction: the UW Faculty Lecturer Award. Pollack is a Founding Fellow of the American Instituteof Medical and Biological Engineering and a Fellow of both the American Heart Association and the BiomedicalEngineering Society. He received an NIH Director's Transformative R01 Award. He was the 2012 recipient of the Prigogine Medal for thermodynamics of dissipative systems,and in 2014 he received the Scientific Excellence Award from the World Academy of Neural Therapy, as well as the Dinsdale Prize from the Society for Scientific Exploration.He has presented two TEDx talks on water. In 2015, he won the BrandLaureate Award, previouslybestowed on notables such as Nelson Mandela, Hillary Clinton and Steve Jobs. In 2016 he was awarded the EmotoInaugural Peace Prize, and more recently the LifetimeAchievement Award from the Chappell Natural Philosophy Society. He appears briefly in the 2016 Travis Rice sports-action film, The Fourth Phase, named after his recentbook. And, he is included in the 2019 listing, OOOM Magazine, as one of the “World's 100 Most Inspiring People.” In 2020, he presented his work at the “Majlis” by invitation from the Crown Prince of Abu Dhabi at his Royal Palace, and more recently, in 2023, at the United Nations. Your Host: Leighton Morrisonhttps://www.instagram.com/kingdomaqua... https://www.kingdomaquaponicsllc.com/  Executive ProducerKen Somerville https://www.instagram.com/kensomerville/ https://www.itsallaboutthebiology.ca Contact emailitsallaboutthebiology@gmail.com Reach out to Ken for a quick 15 mincall:https://calendly.com/kensomerville/connections Help to support the mission: patreon.com/user?u=104510089 Discount codes available at: https://www.itsallaboutthebiology.ca/discountcodes #flowers,#plants,#nature,#gardening,#garden,#growing,#koreannaturalfarming,#naturalfarming,#jadam,#naturalfertilizer,#naturalfarminginputs,#permaculture,#regenerative,#foodforest,#biodynamic,#bioactive,#organic,#notill,#knf,#organicgardening,#urbangardening,#containergardening,#homegardening, Music by The Invisible Gardener (Andy Lopez) https://soundcloud.com/invisiblegardenerFor Full: Disclaimer

Richard Gaster, M.D., Ph.D., is a Managing Partner at venBio with experience as a physician, entrepreneur, and life science investor. Now, a cancer dad. He has helped to launch, invest, and serve on the board of or as board observer of a number of venBio companies. Prior to joining venBio, Dr. Gaster served as the head of translational medicine at Pliant Therapeutics. As a key member of the founding management team, Dr. Gaster was instrumental in the formation and launch of Pliant Therapeutics from Third Rock Ventures where he previously served as a Senior Associate.Dr. Gaster has published numerous articles in top-tier peer-reviewed journals including Nature Medicine and Nature Nanotechnology, holds more than a dozen patents, was awarded first prize in the IEEE Change the World Competition, and was named one of Forbes “30 Under 30” in Science and Healthcare.Dr. Gaster holds a B.S.E in Bioengineering from the University of Pennsylvania where he graduated summa cum laude and was a University Scholar. He received his M.D. and Ph.D. in Bioengineering from Stanford University in the Medical Scientist Training Program.On March 1, 2024, my daughter, Claire experienced a seizure. She was diagnosed with a type of brain cancer called AT/RT (atypical teratoid rhabdoid tumor), a highly aggressive grade IV glioma..... tune in for the rest of the story!You can also get involved with the Gold Ribbon Kids Cancer Foundation or the National Pediatric Cancer Foundation through fundraising, volunteering, promoting awareness, or contributing to pediatric cancer research. Visit goldribbon-kids.org or nationalpcf.org for more informationTo contact Tiffany, please email info@goldribbon-kids.orgTo contact Kelly, please email kgoddard@nationalpcf.orgSupport the show

In this episode, I chatted with Dr. Kaitlyn Sadtler, who is pushing the boundaries of biomedical science. Co-hosted with HHMI Gilliam Fellow and ChemE PhD Candidate Sydney Floryanzia, we talk about their groundbreaking research, the twists and turns of their scientific journeys, and the power of collaboration in tackling big challenges.More on Dr. Sadtler, per the NIBIB:Kaitlyn Sadtler, Ph.D. joined NIBIB as an Earl Stadtman Tenure-Track Investigator and Chief of the Section for Immunoengineering in 2019. Prior to her arrival to the NIH, she completed a postdoctoral fellowship at the Massachusetts Institute of Technology with Daniel Anderson, Ph.D. and Robert Langer, Ph.D., focusing on the molecular mechanisms of medical device fibrosis. During her time at MIT, Dr. Sadtler was awarded an NRSA Ruth L Kirschstein Postdoctoral Fellowship, was listed on BioSpace's 10 Life Science Innovators Under 40 To Watch and StemCell Tech's Six Immunologists and Science Communicators to Follow. In 2018, she was named a TED Fellow and delivered a TED talk which was listed as one of the 25 most viewed talks in 2018. She was also elected to the 2019 Forbes 30 Under 30 List in Science, selected as a 2020 TEDMED Research Scholar, and received multiple other awards. Dr. Sadtler received her Ph.D. from the Johns Hopkins University School of Medicine where her thesis research was published in Science magazine, Nature Methods, and others. She was recently featured in the Johns Hopkins Medicine Magazine as an alumna of note. Dr. Sadtler completed her bachelor's degree summa cum laude at the University of Maryland Baltimore County, followed by a postbaccalaureate IRTA at the Laboratory of Cellular and Molecular Immunology at NIAID.

Can bioengineering and stem cell therapy revolutionize healthcare by focusing on prevention and regeneration rather than just treating symptoms? What if medical science could restore vitality and longevity at the cellular level? In this episode, we sit down with Kevin Caldwell, CEO, Co-Founder, and President of Ossium Health, to explore these game-changing advancements… Ossium Health is a pioneering bioengineering company that leverages organ donor bone marrow banking to develop cutting-edge stem cell therapies. These treatments offer new hope for patients battling life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal disorders. What started as a small startup has grown into a clinical-stage company on a mission to transform regenerative medicine and improve human health. Join us as we discuss: How Kevin's shift in mindset led to the creation of Ossium Health Why modern healthcare struggles with chronic disease management How stem cell therapy is revolutionizing treatment for immune and blood disorders The critical role of cell composition in successful organ transplants Before launching Ossium Health, Kevin worked as an Engagement Manager at McKinsey's San Francisco office, guiding biotech and healthcare companies through market expansion, revenue growth, and strategic restructuring. Now, he's applying that expertise to develop innovative stem cell solutions that could redefine modern medicine. Ready to discover the future of regenerative healthcare? Visit Ossium Health now! Episode also available on Apple Podcasts: https://apple.co/38oMlMr

In this episode, Dr. Joe Casciani is joined by Jennifer Morrison, an expert in vehicle safety at Mazda. Together, they explore the evolving landscape of automotive safety, with a focus on how advanced car technologies can help prolong senior independence. They discuss critical safety features, the importance of behavioral safety, and recommendations for selecting the safest vehicles for older adults. The conversation also touches on car safety ratings, electronic system familiarity, and the potential future of driverless vehicles. Jennifer shares insights on the latest crash avoidance and crash-worthiness features. They also discuss their perspectives on maintaining confidence in driving as we age. The episode concludes with a discussion on the future of autonomous vehicle technology and driverless taxi programs. What are their implications for senior mobility? Mini Bio Jennifer Morrison oversees vehicle safety strategy and communications for Mazda North American Operations. She is responsible for compliance with federal safety regulations, crash testing and consumer rating programs, and the thoughtful deployment of advanced driver assistance technologies for all US vehicles. Jennifer started her career in transportation safety in the Office of Defect Investigations at the National Highway Traffic Safety Administration (NHTSA). She then spent 15 years as a Vehicle Factors Investigator and Investigator-in-Charge at the National Transportation Safety Board (NTSB) where she investigated over 70 major crashes involving trucks, buses, cars, and trains. The experience turned her into a dedicated safety advocate, focusing on collision avoidance, vehicle crashworthiness, and data-driven improvements to transportation safety. Jennifer has degrees in Bioengineering from the University of Pennsylvania and Applied Automotive Technology from Montgomery College. She has held various leadership positions within Washington, DC based automotive industry groups, including the Alliance for Automotive Innovation and the SAE Washington DC Section, where she mentors and connects automotive engineers. For Our Listeners Insurance Institue for Highway Safety: IIHS.org National Highway Traffic Safety Administration: NHTSA.gov Mazda USA

In this episode of The Founder Spirit, Barney Swan, Founder of ClimateForce, an explorer and a gifted keynote speaker, shares stories of planting trees with Dr. Jane Goodall, working with both modern and Indigenous wisdom keepers,  his approach to  mental health and wellbeing in navigating the “attention economy”.  In this conversation, Barney discusses the importance of self-realization and circular economy, honoring what has brought us this far, and how to find common ground on sustainability. He also explores the interconnectedness of biodiversity and the survival of human species, while emphasizing the need for commitment, humility, and humor in creating a safety net for the future. How do we navigate the attention economy and find common ground on sustainability?  TUNE IN to this conversation & find out. For detailed transcript and show notes, please visit TheFounderSpirit.com.Also follow us on: - LinkedIn: https://www.linkedin.com/company/TheFounderSpirit- Instagram:  https://www.instagram.com/TheFounderSpirit- YouTube:  https://www.youtube.com/@TheFounderSpirit- Facebook:  https://www.facebook.com/TheFounderSpirit- X:  https://twitter.com/founder_spiritIf this podcast has been beneficial or valuable to you, feel free to become a patron and support us on Patreon.com, that is P-A-T-R-E-O-N.com/TheFounderSpirit.As always, you can find us on Apple, YouTube and Spotify, as well as social media and our website at TheFounderSpirit.com.The Founder Spirit podcast is proud to be a partner of the Villars Institute, a non-profit foundation focused on accelerating the transition to a net-zero economy and restoring planetary health.About This Podcast:Whether you are an entrepreneur, a mid-career professional or someone who's just starting out in life, The Founder Spirit podcast is for you!In this podcast series, we'll be interviewing exceptional individuals from all over the world with the founder spirit, ranging from social entrepreneurs, tech founders, to philanthropists, elite athletes, and more. Together, we'll uncover not only how they manage to succeed in face of multiple challenges, but also who they are as people and their human story.So TUNE IN & be inspired by stories from their life journey!

Professor Rohit Srivastava shares his vision of transforming India through a 10X innovation mindset, prioritizing patents over papers, and building product-focused ecosystems that turn academic research into market solutions.5-point Episode SummaryThe 10X Impact Framework: Prof. Srivastava's approach to creating 10 times more value through patents, startups, and reaching more patients than conventional academic labs.Patents Over Papers: How filing 250+ patents and co-founding 15 startups is transforming academic research into market solutions for India.Building Innovation Ecosystems: Creating bio-clusters across India to connect universities and accelerate product development through interdisciplinary collaboration.Product-First Thinking: Training students to identify market needs and develop solutions that can reduce India's ₹90,000 crore medical device import bill.From Innovation to Impact: The vision to create thousands of "innovation builders" who will transform India from a service economy to a product powerhouse by 2047.Timestamps00:03:37 - 00:05:56 Mentors Who Shaped My Vision for India 00:05:56 - 00:08:55 India's Forward-Thinking Academic Leaders 00:08:55 - 00:11:47 Making Maximum Impact with Minimum Resources00:11:47 - 00:15:00 Patents vs Papers: The Future of Innovation 00:15:00 - 00:18:03 Why Product-First Thinking Changes Everything 00:18:03 - 00:21:39 The Product-First Mindset Behind Innovation 00:21:39 - 00:25:25 The 10X Impact Framework for Success 00:25:25 - 00:28:47 Building NanoBIOS - an Innovation Ecosystem in Academia 00:28:47 - 00:35:02 Transforming Students into Innovators 00:35:02 - 00:38:52 Why Interdisciplinary Thinking Creates Better Products 00:38:52 - 00:42:04 Cross-Pollinating Innovation with Bioclusters Across Universities00:42:04 - 00:45:02 How Patents Create a Virtuous Cycle of Innovation 00:45:02 - 00:49:08 Advice for Young Academics: Be Innovation Builders 00:49:08 - 00:49:43 Can India Create Its Own Philips or Siemens? 00:49:43 - 00:50:08 What is Success? 00:50:08 - 00:50:29 Advice for 18-Year-Olds in University Today 00:50:29 - 00:51:01 The Best Advice I've Ever Received 00:51:01 - 00:51:54 My Dream Dinner with Innovation Giants 00:51:54 - 00:52:27 The 10X Thinking That People Find Hard to AcceptSelected Links and Show NotesSubscribe to our Weekly NewsletterAbout Prof. Rohit SrivastavaProfessor Rohit Srivastava is a pioneering academic entrepreneur who holds the Himanshu Patel Chair at IIT Bombay's Department of Biosciences and Bioengineering. Known for his revolutionary "10X impact" philosophy and "patents over papers" approach, he has filed over 250 patents and co-founded more than 15 startups in just 19 years. His Nanobios Lab has commercialized numerous affordable medical technologies including UChek (a mobile urine analysis system) and Suchek (an indigenous low-cost glucometer), helping reduce India's dependence on imported medical devices.Honored with the prestigious Shanti Swarup Bhatnagar Prize (2021) and the inaugural Vigyan Shri Award (2024), Prof. Srivastava is transforming how academic research translates to market solutions. This episode was made possible by the great folks at Effortless.Effortless has been designed to be user-friendly, aiding you in your journey to streamline financial tasks. Experience the convenience of achieving e-Invoicing and E-way Bill Generation in just a couple of clicks, simplifying your business processes.#10xImpact, #InnovationIndia, #PatentsOverPapers, #ProductFirstThinking, #StartupEcosystem, #MedicalInnovation, #MakeInIndia, #FrugalInnovation, #IITBombay, #HealthTech, #BioTech, #AcademicEntrepreneurship, #IndianInnovation, #ViksitBharat, #TechForHealth

Hydrogen has great potential for helping society to reach net-zero emissions.  The problem is that the most economical and established production methods for hydrogen depend heavily on fossil fuels and result in roughly a dozen kilograms of carbon dioxide emissions for every kilogram of hydrogen produced. The carbon-free way to produce hydrogen is by splitting […]

Can bioengineering improve the health, vitality, and longevity of human beings? What would the future look like if the medical system were about preserving health rather than just treating symptoms? In this episode, Kevin Caldwell, the CEO, Co-Founder, and President of Ossium Health, sits down to share his thoughts… Ossium Health is a commercial-stage bioengineering company that uses its exclusive organ donor bone marrow banking platform to develop stem cell therapies for patients suffering from life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal defects. Initially built from a small startup, it evolved into the clinical-stage bioengineering company it is today with one primary mission: To improve human health through bioengineering. Join the conversation now to explore: How Kevin's mindset shift in business led to the creation of Ossium.  Why the healthcare system isn't adequately equipped to deal with modern chronic diseases.  Types of cell therapies that provide relief for patients with blood and immune conditions. The role that cell composition plays in the reactivity between donors and recipients.  Before founding Ossium, Kevin worked as an Engagement Manager at McKinsey's San Francisco office, where he advised clients in the biotechnology and healthcare industries. His projects spanned from conducting due diligence on biotech startup acquisitions to restructuring financially distressed biopharma companies. Over the course of his tenure, Kevin led more than 20 engagements for over a dozen clients, guiding teams in strategies for revenue growth, market-entry, and organizational restructuring. To learn about Kevin's cutting-edge work with Ossium Health, visit their website now! Episode also available on Apple Podcasts: https://apple.co/30PvU9C Boost Your Brainpower with 15% OFF!  Fuel your mind with BrainSupreme Supplements and unlock your full potential. Get 15% OFF your order now using this exclusive link: brainsupreme.co/discount/findinggenius Hurry—your brain deserves the best!

(2:30) - AI-designed proteins neutralise snake toxinsThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn more about how AI is being used to expedite the drug development discovery phase! Hint: it's a great primer for this episode :) Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.

Advancements in arrhythmia care are transforming patient outcomes and reshaping clinical practices. Join Dr. Sanjiv Narayan, Professor of Medicine at Stanford University, and Dr. Paul Wang, Professor of Medicine and of Bioengineering at Stanford University, as they explore the evolving field of electrophysiology, highlighting the importance of early detection and best practices in the management of common electrical abnormalities. Discover how a patient-centered approach can enhance care and outcomes for those with irregular heart rhythms. Read Transcript CME Information: https://stanford.cloud-cme.com/medcastepisode99 Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=3229

From 2019: Bioengineering Innovation Outreach Challenge 2019 prize winners by Ian Woolf, Professor Hala Zrieqat talks about the ARC Bioengineering Innovation Centre, Dr Gavinda Singh talks about his research in cancer cures and his mentorship, Team Team from Sydney Girls High School talk about their Epilepsy brainwave monitoring solution, Team Biochis from Mount Carmel Catholic School talk about their nutritional deficiency detecting watch, Team Discovery Channel from Fort St High School talk about implanting an epinephrine dispensor for allergic shock, PhD students Mathilde Longfield and Ben Ferguson talk about mentoring the high school students, Team Exothermics from Sydney Girls High School talks about making scorpion antivenom cheaper and easier to access, Team Tissue Box from Sydney Girls High School talks about her team's water-proof hearing aid. Hosted and produced by Ian Woolf Support Diffusion by making a contribution Team Exothermics from Sydney Girls High School Support Diffusion by buying Merchandise

Brought to you by TogetherLetters & Edgewise!In this episode: Trump administration says it has no plans to fulfill $400 million 'armored Tesla' contractAnyone Can Push Updates to the DOGE.gov WebsiteDOGE Exposes Once-Secret Government Networks, Making Cyber-Espionage Easier than Ever White Hat Hackers Expose Iridium Satellite Security Flaws - Users' locations and texts can be intercepted, including DoD employeesHumane's AI Pin is dead, as HP buys startup's assets for $116MAll of Humane's AI pins will stop working in 10 days​​Elizabeth Holmes Breaks Her Silence in First Interview from Prison: 'It's Been Hell and Torture'​​Bioengineering makes robotic limbs feel naturalThe 20 year old PSP can now connect to WPA2 Wifi NetworkSpotify Weighs $6 Premium for Added Features, Access to TicketsApple unveils cheaper iPhone 16e powerful enough to run AIResearchers link a gene to the emergence of spoken languageWeird and Wacky: That guy who threw away $775 million in Bitcoin wants to buy the whole garbage dumpA humpback whale briefly swallows kayaker in Chilean Patagonia — and it's all captured on cameraWild fish can recognize human diversTech Rec:Sanjay - AutoSlashAdam - Tactical PenFind us here:

February is American Heart Month, and in light of that, we're bringing back an episode about a group here at Stanford Engineering that's developing 3D printing methods for human tissues and organs, a process known as bioprinting. Motivated in part by the critical need for heart transplants, Mark Skylar-Scott and his team are specifically working to bioprint tissues of the human heart. It may sound like science fiction, but it's actually just another example of the groundbreaking research we do here. We hope you'll take another listen and be inspired by the possibilities.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Mark A. Skylar-ScottMark's Lab: The Skylar-Scott Lab | Stanford MedicineConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest, Mark Skylar-Scott, a professor of bioengineering at Stanford University.(00:02:06) What is Bioprinting?The role of cells and biopolymers in printing functional biological structures.(00:03:31) Bioprinting a HeartThe potential of printing organs on demand, especially heart tissue.(00:04:38) Obtaining Cells for BioprintingUsing stem cells derived from the patient's own cells to create heart tissue.(00:06:29) Creating Multiple Cell Types for the HeartThe challenge of printing eleven different heart cell types with precision.(00:08:50) The Scaffold for 3D PrintingThe support material used in 3D printing and how it's later removed.(00:10:10) Cell Migration and Organ FormationHow cells organize themselves to form functional heart tissue.(00:12:08) Growing a Full-Sized HeartWhether they're printing full-sized hearts or starting with smaller organs.(00:13:34) Avoiding Overgrowth RisksThe role of bioreactors in shaping the early stages of the organ.(00:14:57) Scaling Up Cell ProductionThe need to generate massive numbers of cells for experimentation.(00:18:32) The Challenge of VascularizationCreating a blood vessel network to supply oxygen and nutrients.(00:22:35) Ethical Considerations in BioprintingConsent, stem cell sourcing, and the broader ethical landscape.(00:26:04) The Timeline for Bioprinted OrgansThe long timeline for bioprinted organs to reach clinical use.(00:27:24) The State of the Field & CollaborationThe collaborative, competitive biofabrication field and its rapid progress.(00:28:20) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Welcome to Stanford Engineering's The Future of Everything, the podcast that delves into groundbreaking research and innovations that are shaping the world and inventing the future. The University has a long history of doing work to positively impact the world and it's a joy to share about the people who are doing this work, what motivates them, and how their work is creating a better future for everybody. Join us every Friday for new episodes featuring insightful conversations with Stanford faculty and to discover how Stanford's research is transforming tomorrow's world. Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Freedom Broadcastersl Livestream OnJanuary 23, 2025, Thursday 12:00 PM EST Guest: Clifford Carnicom Topic: “Unveiling the Web: Bioengineering, Vaccines, and the Mystery of Morgellons” https://carnicominstitute.org/ https://carnicominstitute.substack.com/ Bio: Clifford Carnicom is the founder of the Carnicom Institute, a nonprofit organization dedicated to researching bioengineering, environmental health, and emerging diseases like Morgellons. With a background in environmental science and technical fields, Carnicom has spent decades uncovering the links between atmospheric aerosols, public health, and systemic challenges to scientific transparency. His work aims to promote awareness and understanding of complex issues affecting humanity and the planet. What we Discussed: - What Should the public be aware of whats in the chemtrails ( 22 mins) - What successes have been seen and who is behind this ( 30 min) - The budget of all the major organisations and what they do with the money (43 mins) - We do not have time to convince people (47:30 mins) - The attention of the World is on the wrong thing (51 min) - Does he have hope and does he see results ( 53 mins) - Should we be worried about the current Fogs (54 mins to 1hr ) - The eco system is being effected ( 1 hr) - The plan is to take pictures of the chemtrails see around the world ( 1 hr 7 mins) - Not all Apps not showing the flights of Chemtrails ( 1 hr 14 mins) - Serbia weather also effected ( 1 hr 17 mins) Creator Host: Grace Asagra, RN MA Podcast: Quantum Nursehttps://www.quantumnurse.life/ SpecialGuest Host: Atty David Meiswinklehttps://nationalarm.org/ SpecialGuest Host: Drago Bosnic BRICS portal(infobrics.org)https://t.me/CerFunhouse Co-host:Roy Coughlan Podcast: AWAKENING https://www.awakeningpodcast.org/

Imagine a future in which Band-Aids talk to your cells, pacemakers are powered by light and your gut microbiome gets a tune-up—all thanks to tiny bioelectric devices. Sounds like sci-fi, right? Think again. Prof. Bozhi Tian of the University of Chicago is on the frontier of bioelectronics, building living machines that can heal, enhance and maybe even transform what it means to be human. In this episode, he explains his research lab's work and explores the thrilling, strange and sometimes unsettling world in which biology meets technology.

Quantum Nurse http://graceasagra.bio.link/ presents Freedom International Livestream On January 23, 2025, Thursday 12:00 PM EST Guest: Clifford Carnicom Topic: “Unveiling the Web: Bioengineering, Vaccines, and the Mystery of Morgellons” https://carnicominstitute.org/  https://carnicominstitute.substack.com/ Bio: Clifford Carnicom is the founder of the Carnicom Institute, a nonprofit organization dedicated to researching bioengineering, environmental health, and emerging diseases like Morgellons. With a background in environmental science and technical fields, Carnicom has spent decades uncovering the links between atmospheric aerosols, public health, and systemic challenges to scientific transparency. His work aims to promote awareness and understanding of complex issues affecting humanity and the planet. Creator Host: Grace Asagra, RN MA  Podcast:  Quantum Nurse: Out of the Rabbit Hole from Stress to Bliss  http://graceasagra.bio.link/ https://www.quantumnurse.life/ Bichute https://www.bitchute.com/channel/nDjE6Ciyg0ED/ TIP/DONATE LINK for Grace Asagra @ Quantum Nurse Podcast https://patron.podbean.com/QuantumNurse https://www.paypal.com/donate/?hosted_button_id=FHUXTQVAVJDPU Venmo - @Grace-Asagra 609-203-5854  WELLNESS RESOURCES • Optimal Health and Wellness with Grace Virtual Dispensary Link (Designs for Health)    2https://www.designsforhealth.com/u/optimalhealthwellness • Quantum Nurse Eternal Health (Face Skin Care, Protein Powder and Elderberry) https://www.quantumnurseeternalhealth.com/ Special Guest Host: Atty David Meiswinkle https://nationalarm.org/ Special Guest Host: Drago Bosnic BRICS portal (infobrics.org) https://t.me/CerFunhouse Co-host: Roy Coughlan Podcast: AWAKENING https://www.awakeningpodcast.org/  

In this episode of HealthiHer, Dr. Brenner is joined by guest Dr. Kerry Reller, MD, MS, to uncover the surprising benefits of Semaglutide: beyond weight loss. While Semaglutide has gained popularity as a breakthrough treatment for obesity and type 2 diabetes, emerging research reveals its remarkable potential in addressing a variety of health challenges. From improving cardiovascular health and reducing the risks of heart disease to alleviating conditions like sleep apnea, this therapy is proving to be a game-changer in many ways few expected. In this episode, Dr. Brenner and Dr. Reller delve into: How Semaglutide works in the body and its broader therapeutic potential. The impact of GLP-1 medications on cardiovascular outcomes and disease prevention. Semaglutide's surprising role in improving sleep apnea and quality of life. Insights into how this treatment could shape the future of women's health and beyond. Whether you're curious about the science behind GLP-1s, seeking alternative ways to improve your health, or simply interested in the latest breakthroughs in medicine, this episode is packed with expert advice and actionable insights. Join us for this enlightening discussion that highlight the surprising benefits of Semaglutide: beyond weight loss and how it is redefining health care and transforming lives in unexpected ways! Is Semaglutide right for you? Take our quiz to find out – like and subscribe!  Instagram- https://www.instagram.com/amybrennermd/ Facebook- https://www.facebook.com/DoctorAmyBrenner YouTube- https://www.youtube.com/c/AmyBrennerMD Special Guest –Kerry Reller, MD, MS Dr. Kerry Reller is board certified in Family and Community Medicine and Obesity Medicine and works at Clearwater Family Medicine and Allergy in Clearwater and Palm Harbor, FL.  She completed her BS in Electrical Engineering from the University of Notre Dame and MS at Georgia Tech focusing in Bioengineering.  While working in systems engineering at a defense contractor, she realized she was not utilizing her skills and passion to help others.  She resigned from her engineering job and completed premedical requirements at The Johns Hopkins University, medical school and residency at the University of Maryland in Family Medicine.  She moved back to Florida to join her father in practice and to learn the clinical practices of Allergy, Asthma, and Immunology. She started her own family practice in July 2017 in addition to seeing allergy patients.   Dr. Reller later found her passion and completed board certification in Obesity Medicine. Find Kerry Reller, MD: website: www.clearwaterfamilymedicine.health Instagram: @clearwaterfamilymedicine Facebook: Clearwater Family Medicine & Allergy YouTube: @kerryrellermd TikTok: Kerryrellermd Podcast: Get Healthy Tampa Bay Checkout Dr. Reller’s podcast featuring Dr. Brenner 

This week on Data in Biotech, we welcome Timothy Jenkins, the Head of Data Science and Associate Professor at DTU Bioengineering, a leading scientific community dedicated to advancing areas of biotechnology, food technology, and health through innovative teaching and research.  Timothy starts the conversation by walking us through his background and early career beginnings, from the first time he expressed interest in zoology and venomous snakes to now leading a research group focused on AI-guided drug discovery for snake antivenom. He and our host, Ross Katz, dive into one of DTU's most exciting recent publications about "de novo" designed proteins to neutralize lethal snake venom toxins.  Inspired by Nobel Prize winner David Baker's groundbreaking paper and in collaboration with the Baker Lab on computational design methodology, this project holds great promise in therapeutic discovery and drug development. Tim explains how computational protein design and protein structure prediction are revolutionizing his field, highlighting compelling examples and milestones from his research on antivenom. He also provides an overview of the process used to discover new antivenoms, including the sourcing of biological data, model training, and integration of experimental feedback. Finally, we get Tim's perspective on the future of AI-powered therapeutic discovery, and his take on the integration of quantum computing into protein design. Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in the life sciences. Useful Links Nature - De novo designed proteins neutralize lethal snake venom toxins Timothy's LinkedIn DTU Bioengineering Website UW Institute for Protein Design “de novo” designed proteins project Information on Nobel Prize winner David Baker

The global onset of the coronavirus shut down schools, which interrupted the educational process for millions of students. The expectation was that deficits in fundamental areas would be made up once the world opened up again. Did that happen though? Amy and Mike invited education professional Nancy Weinstein to explore post-pandemic learning loss.  What are five things you will learn in this episode? Are students really performing differently since the pandemic?  Does learning loss differ based on age or gender? Were students in all parts of the United States equally impacted by the pandemic? How can students begin to repair pandemic learning gaps? What can parents, educators, and coaches do to repair pandemic learning loss? MEET OUR GUEST Nancy Weinstein founded Mindprint Learning with the perspectives of both a parent and an innovator.  Realizing a need to address a common challenge for parents and educators, she drew upon her background in science and business to create Mindprint, the first ever valid at-home cognitive assessment supported with next-step strategies for growth. Nancy has an extensive background in business, including work at Goldman Sachs, The Walt Disney Company Corporate Strategic Planning, Bristol Myers Squibb, and several smaller Internet companies. Nancy has an MBA from Harvard Business School with first year honors and a BS/BSE summa cum laude from the University of Pennsylvania and Wharton School of Management and Technology Program, Bioengineering and Finance. As a mother of two, Nancy recognizes the challenges parents face today, from helping with homework, to navigating the ever-changing pace of education and technology.  Nancy previously appeared on this podcast in episode 132 to discuss The Science of Memory. Find Nancy at https://mindprintlearning.com/. LINKS MindPrint Research Brief - Post Pandemic Brain Changes: Results from 35K Students Study Finds COVID Harmed Cognitive Skills of Students — and Teachers – The 74 RELATED EPISODES COVID LEARNING LOSS THE GROWING IMPACT OF CHEATING DURING COVID HOW TESTS AID MEMORY ABOUT THIS PODCAST Tests and the Rest is THE college admissions industry podcast. Explore all of our past episodes on the show page and keep up with our future ones by subscribing to our email newsletter. ABOUT YOUR HOSTS Mike Bergin is the president of Chariot Learning and founder of TestBright. Amy Seeley is the president of Seeley Test Pros and LEAP. If you're interested in working with Mike and/or Amy for test preparation, training, or consulting, feel free to get in touch through our contact page.  

Are exosomes the planet's ultimate healing tool?! In this episode, Dave Asprey sits down with Harvard-trained physician Dr. Edward Park to explore the groundbreaking science of exosomes. Dr. Park, a pioneer in regenerative medicine and author of Exosomes: Songs of Healing, explains how these tiny cellular messengers are revolutionizing health and longevity by bypassing the limitations of stem cells. BUT this episode isn't just about cutting-edge science. Dr. Park also shares profound insights into life, resilience, and emotional well-being, offering advice that goes far beyond medicine. From the power of forgiveness to breaking free of limiting beliefs, his perspective blends science, spirituality, and practical wisdom for living a better life. Here's what you'll learn in this episode: • How exosomes work and why they're being called the future of regenerative medicine • The key differences between exosomes and stem cells—and which is better for healing • Real-life applications of exosome therapy for injuries, anti-aging, and overall health • The potential of exosomes to enhance brain function, reduce inflammation, and promote recovery • Dr. Park's advice on emotional resilience, gratitude, and creating lasting change With over a decade of experience, Dr. Park shares compelling case studies, cutting-edge insights, and practical advice for anyone looking to upgrade their body, mind, and life. Whether you're managing chronic pain, exploring anti-aging therapies, or seeking wisdom for navigating life's challenges, this episode has something for everyone. Sponsors TRU KAVA | Go to https://trukava.com and enter code DAVE15 at checkout for 15% off Resources: • 2025 Biohacking Conference – https://biohackingconference.com/2025 • Dr. Edward Park's Website: Recharge Biomedical – https://www.rechargebiomedical.com • Dr. Edward Park's Book: Exosomes: Songs of Healing – https://www.amazon.com/EXOSOMES-Songs-Healing-Ed-Park/dp/098260632X • Dr. Edward Park's YouTube Channel – https://www.youtube.com/channel/UCpp9DlRArB1rKAWNwoouiTg • Dr. Edward Park on Instagram – https://www.instagram.com/dredpark/ • Dave Asprey's Website – https://daveasprey.com • Dave Asprey's Book: Smarter Not Harder – https://daveasprey.com/books • Danger Coffee – https://dangercoffee.com • Danger Coffee Instagram – https://www.instagram.com/dangercoffeeofficial/ • Dave Asprey's Linktree – https://linktr.ee/daveasprey • Upgrade Collective: Join The Human Upgrade Podcast Live – https://www.ourupgradecollective.com • Own an Upgrade Labs – https://ownanupgradelabs.com • Upgrade Labs – https://upgradelabs.com • 40 Years of Zen – Neurofeedback training for advanced cognitive enhancement – https://40yearsofzen.com Timestamps: • 00:00 Introduction to Exosomes and Healing • 00:48 Understanding Exosomes: Stem Cell Communication • 01:19 Dr. Edward Park's Insights on Exosomes • 02:47 Exosomes vs. Traditional Treatments • 04:44 Exosomes in Regenerative Medicine • 07:33 Cost-Effective Regeneration Protocols • 12:35 Exosomes for Hair Growth • 14:37 Stem Cells and Brain Health • 25:33 Banking Stem Cells for Future Use • 35:27 Epigenetic Age and Longevity Predictors • 37:48 CRISPR and Gene Editing: Risks and Benefits • 39:43 Basic Health Tips for Longevity • 41:02 Spirituality, Past Lives, and Healing • 42:50 Questioning Medical and Political Narratives • 47:54 The Importance of Free Speech • 01:07:40 The Role of Intuition in Medicine • 01:09:22 Conclusion and Final Thoughts See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.